biotech

upgrade

Canaccord Genuity Doubles Price Target for Medivation

Medivation Inc. (NASDAQ: MDVN) received an upgrade from Canaccord Genuity on the heels of it continually increasing its 52-week high over the past month. This upgrade comes on analyst John ...
Read Full Story »
152498601

Flexion Therapeutics Stumbles on Clinical Hold

In the after-hours on Wednesday, Flexion Therapeutics Inc. (NASDAQ: FLXN) made a hard fall on the news of a clinical hold. Usually clinical holds result in some serious fall out ...
Read Full Story »
biotech

Analyst Sees Incyte Worth 70% More

Incyte Corp. (NASDAQ: INCY) has serious upside potential, but the inherent risk within it may be too much for some investors to bear. This stock is not for the risk ...
Read Full Story »
Biotechnology word cloud

Why Endo Wants to Acquire Auxilium So Much

Endo International PLC (NASDAQ: ENDP) made an unsolicited buyout offer to Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). This news comes right after Auxilium announced that it entered into an agreement to ...
Read Full Story »
95992888

Is Avanir Pharma Fully Valued After Monday’s Rally?

Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) posted amazing gains on Monday following the announcement of a successful Phase 1 trial for AVP-923. On the day, Avanir's stock price rose by 85% to ...
Read Full Story »
health care

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

For a variety of reasons, the cases of chronic hepatitis in the United States have surged dramatically over the past 20 years. Currently, it is estimated that more than 3.2 ...
Read Full Story »
481519631

Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs

Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) announced positive Phase 2 results for its drug candidate AVP-923. The drug candidate is a potential new therapy for agitation and aggression in patients with ...
Read Full Story »
research

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

NPS Pharmaceuticals Inc. (NASDAQ: NPSP) is trading lower on what sounded like good news. The problem is that headlines often do not reveal the underlying story. After its shares were ...
Read Full Story »
Biotechnology word cloud

Short Sellers Remain Vigilant Against Biotechs

The short interest report is out for the August 29 settlement date, and 24/7 Wall St. is focusing on the biotech sector. Short sellers are often active in biotech stocks, ...
Read Full Story »
DNA

Virobay Files For Initial Public Offering

Virobay, Inc. has filed with the Securities and Exchange Commission for an initial public offering. There were no terms given for the offering but the filing is for up to $50 million ...
Read Full Story »
Biotechnology word cloud

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Biotech stock investing can be a nerve-racking experience for investors, especially if they are focused on the companies that are waiting on some sort of binary event or clinical data ...
Read Full Story »
Biotechnology word cloud

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

The firms we cover on Wall Street are sometimes like covering the major sports teams. Analysts are like the top players and tend to move around as their career strengths ...
Read Full Story »
153576724

EndoStim Files for IPO: The Next Big GERD Treatment?

EndoStim Inc. filed with the Securities and Exchange Commission Friday to have an initial public offering (IPO). There were no terms given in the filing but the offering is valued ...
Read Full Story »
health care

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval from the FDA on its most recent drug Ferric Citrate, formerly known as Zerenex. The drug is ...
Read Full Story »
research

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

Prana Biotechnology Ltd. (NASDAQ: PRAN) saw its shares surge on Friday. This movement is on the heels of the U.S. Food and Drug Administration (FDA) granting an orphan drug designation to ...
Read Full Story »